FDMT logo

FDMT Non Current Assets

Annual Non Current Assets

$125.45 M
+$82.15 M+189.71%

December 1, 2024


Summary


Performance

FDMT Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFDMTbalance sheetmetrics:

Quarterly Non Current Assets

$125.45 M
+$32.18 M+34.50%

December 1, 2024


Summary


Performance

FDMT Quarterly Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFDMTbalance sheetmetrics:

Non Current Assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

FDMT Non Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+189.7%+85.9%
3 y3 years+29.1%+275.9%
5 y5 years+2090.9%+275.9%

FDMT Non Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+203.5%at high+275.9%
5 y5-yearat high+2110.6%at high+2135.0%
alltimeall timeat high+4347.1%at high+4224.4%

4D Molecular Therapeutics Non Current Assets History

DateAnnualQuarterly
Dec 2024
$434.93 M(+46.6%)
$125.45 M(+34.5%)
Sep 2024
-
$93.27 M(+38.2%)
Jun 2024
-
$67.48 M(-28.4%)
Mar 2024
-
$94.30 M(+117.8%)
Dec 2023
$296.59 M(+34.5%)
$43.30 M(+29.8%)
Sep 2023
-
$33.37 M(-3.9%)
Jun 2023
-
$34.73 M(-6.1%)
Mar 2023
-
$36.98 M(-10.5%)
Dec 2022
$220.51 M
$41.34 M(-13.3%)
Sep 2022
-
$47.69 M(-15.5%)
Jun 2022
-
$56.41 M(-31.1%)
DateAnnualQuarterly
Mar 2022
-
$81.88 M(-15.8%)
Dec 2021
$256.28 M(-9.3%)
$97.21 M(+29.8%)
Sep 2021
-
$74.89 M(+1111.3%)
Jun 2021
-
$6.18 M(+10.1%)
Mar 2021
-
$5.61 M(-1.1%)
Dec 2020
$282.66 M(+438.3%)
$5.67 M(+0.3%)
Sep 2020
-
$5.66 M(-1.2%)
Dec 2019
$52.51 M(-44.2%)
$5.73 M(+13.3%)
Jun 2019
-
$5.05 M(+74.3%)
Dec 2018
$94.07 M(+284.0%)
$2.90 M
Dec 2017
$24.50 M
-

FAQ

  • What is 4D Molecular Therapeutics annual long term assets?
  • What is the all time high annual non current assets for 4D Molecular Therapeutics?
  • What is 4D Molecular Therapeutics annual non current assets year-on-year change?
  • What is 4D Molecular Therapeutics quarterly long term assets?
  • What is the all time high quarterly non current assets for 4D Molecular Therapeutics?
  • What is 4D Molecular Therapeutics quarterly non current assets year-on-year change?

What is 4D Molecular Therapeutics annual long term assets?

The current annual non current assets of FDMT is $125.45 M

What is the all time high annual non current assets for 4D Molecular Therapeutics?

4D Molecular Therapeutics all-time high annual long term assets is $125.45 M

What is 4D Molecular Therapeutics annual non current assets year-on-year change?

Over the past year, FDMT annual long term assets has changed by +$82.15 M (+189.71%)

What is 4D Molecular Therapeutics quarterly long term assets?

The current quarterly non current assets of FDMT is $125.45 M

What is the all time high quarterly non current assets for 4D Molecular Therapeutics?

4D Molecular Therapeutics all-time high quarterly long term assets is $125.45 M

What is 4D Molecular Therapeutics quarterly non current assets year-on-year change?

Over the past year, FDMT quarterly long term assets has changed by +$57.97 M (+85.90%)